Extracorporeal membrane oxygenation in obstetric patients: An Israeli nationwide study.
ECMO
nationwide study
peripartum complications
Journal
Artificial organs
ISSN: 1525-1594
Titre abrégé: Artif Organs
Pays: United States
ID NLM: 7802778
Informations de publication
Date de publication:
19 Dec 2023
19 Dec 2023
Historique:
revised:
19
11
2023
received:
12
08
2023
accepted:
26
11
2023
medline:
19
12
2023
pubmed:
19
12
2023
entrez:
19
12
2023
Statut:
aheadofprint
Résumé
The leading causes of maternal mortality include respiratory failure, cardiovascular events, infections, and hemorrhages. The use of extracorporeal membrane oxygenation (ECMO) as rescue therapy in the peripartum period for cardiopulmonary failure is expanding in critical care medicine. This retrospective observational study was conducted on a nationwide cohort in Israel. During the 3-year period, between September 1, 2019, and August 31, 2022, all women in the peripartum period who had been supported by ECMO for respiratory or circulatory failure at 10 large Israeli hospitals were identified. Indications for ECMO, maternal and neonatal outcomes, details of ECMO support, and complications were collected. During the 3-year study period, in Israel, there were 540 234 live births, and 28 obstetric patients were supported by ECMO, with an incidence of 5.2 cases per 100 000 or 1 case per 19 000 births (when excluding patients with COVID-19, the incidence will be 2.5 cases per 100 000 births). Of these, 25 were during the postpartum period, of which 16 (64%) were connected in the PPD1, and 3 were during pregnancy. Eighteen patients (64.3%) were supported by V-V ECMO, 9 (32.1%) by V-A ECMO, and one (3.6%) by a VV-A configuration. Hypoxic respiratory failure (ARDS) was the most common indication for ECMO, observed in 21 patients (75%). COVID-19 was the cause of ARDS in 15 (53.7%) patients. The indications for the V-A configuration were cardiomyopathy (3 patients), amniotic fluid embolism (2 patients), sepsis, and pulmonary hypertension. The maternal and fetal survival rates were 89.3% (n = 25) and 100% (n = 28). The average ECMO duration was 17.6 ± 18.6 days and the ICU stay was 29.8 ± 23.8 days. Major bleeding complications requiring surgical intervention were observed in one patient. The incidence of using ECMO in the peripartum period is low. The maternal and neonatal survival rates in patients treated with ECMO are high. These results show that ECMO remains an important treatment option for obstetric patients with respiratory and/or cardiopulmonary failure.
Sections du résumé
BACKGROUND
BACKGROUND
The leading causes of maternal mortality include respiratory failure, cardiovascular events, infections, and hemorrhages. The use of extracorporeal membrane oxygenation (ECMO) as rescue therapy in the peripartum period for cardiopulmonary failure is expanding in critical care medicine.
METHODS
METHODS
This retrospective observational study was conducted on a nationwide cohort in Israel. During the 3-year period, between September 1, 2019, and August 31, 2022, all women in the peripartum period who had been supported by ECMO for respiratory or circulatory failure at 10 large Israeli hospitals were identified. Indications for ECMO, maternal and neonatal outcomes, details of ECMO support, and complications were collected.
RESULTS
RESULTS
During the 3-year study period, in Israel, there were 540 234 live births, and 28 obstetric patients were supported by ECMO, with an incidence of 5.2 cases per 100 000 or 1 case per 19 000 births (when excluding patients with COVID-19, the incidence will be 2.5 cases per 100 000 births). Of these, 25 were during the postpartum period, of which 16 (64%) were connected in the PPD1, and 3 were during pregnancy. Eighteen patients (64.3%) were supported by V-V ECMO, 9 (32.1%) by V-A ECMO, and one (3.6%) by a VV-A configuration. Hypoxic respiratory failure (ARDS) was the most common indication for ECMO, observed in 21 patients (75%). COVID-19 was the cause of ARDS in 15 (53.7%) patients. The indications for the V-A configuration were cardiomyopathy (3 patients), amniotic fluid embolism (2 patients), sepsis, and pulmonary hypertension. The maternal and fetal survival rates were 89.3% (n = 25) and 100% (n = 28). The average ECMO duration was 17.6 ± 18.6 days and the ICU stay was 29.8 ± 23.8 days. Major bleeding complications requiring surgical intervention were observed in one patient.
CONCLUSIONS
CONCLUSIONS
The incidence of using ECMO in the peripartum period is low. The maternal and neonatal survival rates in patients treated with ECMO are high. These results show that ECMO remains an important treatment option for obstetric patients with respiratory and/or cardiopulmonary failure.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023 International Center for Artificial Organ and Transplantation (ICAOT) and Wiley Periodicals LLC.
Références
GBD 2015 Maternal Mortality Collaborators. Global, regional, and national levels of maternal mortality, 1990-2015: a systematic analysis for the global burden of disease study 2015. Lancet. 2016;388(10053):1775-1812. https://doi.org/10.1016/S0140-6736(16)31470-2
Petersen EE, Davis NL, Goodman D, Cox S, Mayes N, Johnston E, et al. Vital signs: pregnancy-related deaths, United States, 2011-2015, and strategies for prevention, 13 states, 2013-2017. MMWR Morb Mortal Wkly Rep. 2019;68(18):423-429. https://doi.org/10.15585/mmwr.mm6818e1
Naoum EE, Chalupka A, Haft J, MacEachern M, Vandeven CJM, Easter SR, et al. Extracorporeal life support in pregnancy: a systematic review. J Am Heart Assoc. 2020;9(13):e016072. https://doi.org/10.1161/JAHA.119.016072
Wong MJ, Bharadwaj S, Galey JL, Lankford AS, Galvagno S, Kodali BS. Extracorporeal membrane oxygenation for pregnant and postpartum patients. Anesth Analg. 2022;135(2):277-289. https://doi.org/10.1213/ANE.0000000000005861
Mariani S, De Piero ME, Ravaux JM, Saelmans A, Kawczynski MJ, van Bussel BCT, et al. Temporary mechanical circulatory support for COVID-19 patients: a systematic review of literature. Artif Organs. 2022;46(7):1249-1267. https://doi.org/10.1111/aor.14261
Conrad SA, Broman LM, Taccone FS, Lorusso R, Malfertheiner MV, Pappalardo F, et al. The extracorporeal life support organization Maastricht treaty for nomenclature in extracorporeal life support. A position paper of the extracorporeal life support organization. Am J Respir Crit Care Med. 2018;198(4):447-451. https://doi.org/10.1164/rccm.201710-2130CP
https://www.merckmanuals.com/. Accessed 01 Apr 2023.
ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, et al. Acute respiratory distress syndrome: the Berlin definition. JAMA. 2012;307(23):2526-2533. https://doi.org/10.1001/jama.2012.5669
Hill JD, O'Brien TG, Murray JJ, Dontigny L, Bramson ML, Osborn JJ, et al. Prolonged extracorporeal oxygenation for acute post-traumatic respiratory failure (shock-lung syndrome). Use of the Bramson membrane lung. N Engl J Med. 1972;286(12):629-634. https://doi.org/10.1056/NEJM197203232861204
Hill JD, Ratliff JL, Fallat RJ, Tucker HJ, Lamy M, Dietrich HP, et al. Prognostic factors in the treatment of acute respiratory insufficiency with long-term extracorporeal oxygenation. J Thorac Cardiovasc Surg. 1974;68(6):905-917.
Bartlett RH, Gazzaniga AB, Fong SW, Burns NE. Prolonged extracorporeal cardiopulmonary support in man. J Thorac Cardiovasc Surg. 1974;68(6):918-932.
Cerene A, Barthelemy B, Vives M, Dupin B, Puel P, Enjalbert A, et al. Assistance respiratoire par circulation extracorporelle de longue durée. A propos d'un cas de syndrome de mendelson traité avec succès [Respiratory support by long-term extracorporeal circulation with a report of a successfully treated case of mendelson's syndrome]. Ann Chir Thorac Cardiovasc. 1977;16(1):35-37. French.
Zapol WM, Snider MT, Hill JD, Fallat RJ, Bartlett RH, Edmunds LH, et al. Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study. JAMA. 1979;242(20):2193-2196. https://doi.org/10.1001/jama.242.20.2193
Brogan TV, Thiagarajan RR, Rycus PT, Bartlett RH, Bratton SL. Extracorporeal membrane oxygenation in adults with severe respiratory failure: a multi-center database. Intensive Care Med. 2009;35(12):2105-2114. https://doi.org/10.1007/s00134-009-1661-7
Peek GJ, Mugford M, Tiruvoipati R, Wilson A, Allen E, Thalanany MM, et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet. 2009;374(9698):1351-1363. https://doi.org/10.1016/S0140-6736(09)61069-2
Kumar A, Zarychanski R, Pinto R, Cook DJ, Marshall J, Lacroix J, et al. Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA. 2009;302(17):1872-1879. https://doi.org/10.1001/jama.2009.1496
Australia and New Zealand Extracorporeal Membrane Oxygenation (ANZ ECMO) Influenza Investigators, Davies A, Jones D, Bailey M, Beca J, Bellomo R, et al. Extracorporeal membrane oxygenation for 2009 influenza A(H1N1) acute respiratory distress syndrome. JAMA. 2009;302(17):1888-1895. https://doi.org/10.1001/jama.2009.1535
Taha B, Guglielminotti J, Li G, Landau R. Utilization and outcomes of extracorporeal membrane oxygenation in obstetric patients in the United States, 1999-2014: a retrospective cross-sectional study. Anesth Analg. 2022;135(2):268-276. https://doi.org/10.1213/ANE.0000000000005753
Lapinsky SE. Management of acute respiratory failure in pregnancy. Semin Respir Crit Care Med. 2017;38(2):201-207. https://doi.org/10.1055/s-0037-1600909
Nair P, Davies AR, Beca J, Bellomo R, Ellwood D, Forrest P, et al. Extracorporeal membrane oxygenation for severe ARDS in pregnant and postpartum women during the 2009 H1N1 pandemic. Intensive Care Med. 2011;37(4):648-654. https://doi.org/10.1007/s00134-011-2138-z
Pham T, Combes A, Rozé H, Chevret S, Mercat A, Roch A, et al. Extracorporeal membrane oxygenation for pandemic influenza A(H1N1)-induced acute respiratory distress syndrome: a cohort study and propensity-matched analysis. Am J Respir Crit Care Med. 2013;187(3):276-285. https://doi.org/10.1164/rccm.201205-0815OC
Malfertheiner SF, Brodie D, Burrell A, Taccone FS, Broman LM, Shekar K, et al. Extracorporeal membrane oxygenation during pregnancy and peripartal. An international retrospective multicenter study. Perfusion. 2023;38:966-972. https://doi.org/10.1177/02676591221090668
O'Neil ER, Lin H, Shamshirsaz AA, Naoum EE, Rycus PR, Alexander PMA, et al. Pregnant and peripartum women with COVID-19 have high survival with extracorporeal membrane oxygenation: an extracorporeal life support organization registry analysis. Am J Respir Crit Care Med. 2022;205(2):248-250. https://doi.org/10.1164/rccm.202109-2096LE
Yin O, Richley M, Hadaya J, Mei J, Mok T, Fahim M, et al. Extracorporeal membrane oxygenation in pregnancy: a bridge to delivery and pulmonary recovery for COVID-19-related severe respiratory failure. Am J Obstet Gynecol. 2022;226(4):571-576.e5. https://doi.org/10.1016/j.ajog.2021.12.024
Mohammed Bamasood O, Shamsah M, Alfoudri H, Bitar Z, Al Shammari FR, Jagadeesan J, et al. Extracorporeal membrane oxygenation in pregnant women with COVID-19. ASAIO J. 2022;68(4):471-477. https://doi.org/10.1097/MAT.0000000000001646
El Banayosy AM, El Banayosy A, Smith JG, Brewer JM, Mihu MR, Swant LV, et al. Extracorporeal life support in pregnant and postpartum women with COVID-19-related acute respiratory distress syndrome. Int J Artif Organs. 2023;46:289-294. https://doi.org/10.1177/03913988231168431
Fatnic E, Blanco NL, Cobiletchi R, Goldberger E, Tevet A, Galante O, et al. Outcome predictors and patient progress following delivery in pregnant and postpartum patients with severe COVID-19 pneumonitis in intensive care units in Israel (OB-COVICU): a nationwide cohort study. Lancet Respir Med. 2023;11:520-529. Erratum in: Lancet Respir Med. 2023;11(4):e38. doi:10.1016/S2213-2600(22)00491-X
Sharma NS, Wille KM, Bellot SC, Diaz-Guzman E. Modern use of extracorporeal life support in pregnancy and postpartum. ASAIO J. 2015;61(1):110-114. https://doi.org/10.1097/MAT.0000000000000154
Lankford AS, Chow JH, Jackson AM, Wallis M, Galvagno SM Jr, Malinow AM, et al. Clinical outcomes of pregnant and postpartum extracorporeal membrane oxygenation patients. Anesth Analg. 2021;132(3):777-787. https://doi.org/10.1213/ANE.0000000000005266
Meng ML, Landau R, Viktorsdottir O, Banayan J, Grant T, Bateman B, et al. Pulmonary hypertension in pregnancy: a report of 49 cases at four tertiary north American sites. Obstet Gynecol. 2017 Mar;129(3):511-520. https://doi.org/10.1097/AOG.0000000000001896
Skolnik S, Ioscovich A, Eidelman LA, Davis A, Shmueli A, Aviram A, et al. Anesthetic management of amniotic fluid embolism - a multi-center, retrospective, cohort study. J Matern Fetal Neonatal Med. 2019;32(8):1262-1266. https://doi.org/10.1080/14767058.2017.1404024
Aissi James S, Klein T, Lebreton G, Nizard J, Chommeloux J, Bréchot N, et al. Amniotic fluid embolism rescued by venoarterial extracorporeal membrane oxygenation. Crit Care. 2022;26(1):96. https://doi.org/10.1186/s13054-022-03969-3
Bouabdallaoui N, Demondion P, Leprince P, Lebreton G. Short-term mechanical circulatory support for cardiogenic shock in severe peripartum cardiomyopathy: La Pitié-Salpêtrière experience. Interact Cardiovasc Thorac Surg. 2017;25(1):52-56. https://doi.org/10.1093/icvts/ivx106
Desai M, Osborn E, King C, Shlobin OA, Psotka M, Ryan L, et al. Extracorporeal life support for cardiogenic shock during pregnancy and postpartum: a single center experience. Perfusion. 2022;37(5):493-498. https://doi.org/10.1177/02676591211004369
Ull C, Schildhauer TA, Strauch JT, Mügge A, Swol J. Veno-venous ECMO as a safe bridge to recovery in a patient with severe peripartum cardiomyopathy - learning from errors. Perfusion. 2017;32(4):328-332. https://doi.org/10.1177/0267659116681436
Huang KY, Li YP, Lin SY, Shih JC, Chen YS, Lee CN. Extracorporeal membrane oxygenation application in post-partum hemorrhage patients: is post-partum hemorrhage contraindicated? J Obstet Gynaecol Res. 2017;43(10):1649-1654. https://doi.org/10.1111/jog.13426
Biderman P, Carmi U, Setton E, Fainblut M, Bachar O, Einav S. Maternal salvage with extracorporeal life support: lessons learned in a single center. Anesth Analg. 2017 Oct;125(4):1275-1280. https://doi.org/10.1213/ANE.0000000000002262 PMID: 28719429.
van den Bosch OFC, Chaudhry R, Wicker J, Mubashir T, Limb D, Jogendran R, et al. Predictors and hospital outcomes in pregnant patients undergoing extracorporeal membrane oxygenation: a Nationwide study. Anesth Analg. 2022;135(6):1172-1179. https://doi.org/10.1213/ANE.0000000000006210
Sitter M, Pecks U, Rüdiger M, Friedrich S, Fill Malfertheiner S, Hein A, et al. Pregnant and postpartum women requiring intensive care treatment for COVID-19 - first data from the CRONOS-registry. J Clin Med. 2022;11(3):701. https://doi.org/10.3390/jcm11030701
Péju E, Belicard F, Silva S, Hraiech S, Painvin B, Kamel T, et al. Management and outcomes of pregnant women admitted to intensive care unit for severe pneumonia related to SARS-CoV-2 infection: the multicenter and international COVIDPREG study. Intensive Care Med. 2022;48(9):1185-1196. https://doi.org/10.1007/s00134-022-06833-8